Showing results (121-130 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1978
Delayed type hypersensitivity in mice immunized with inactivated rabies virusP H Lagrange, H Tsiang, B HurtrelDevelopments in Biological Standardization|January 1, 1977
Evidence of tumorigenic activity of candidate cell substrates in vaccine production by use of antilymphocyte serumH Glathe, C AbelDevelopments in Biological Standardization|January 1, 1996
Problems encountered in the delivery and storage of OPV in an African countryB D Schoub, N A CameronDevelopments in Biological Standardization|January 1, 1996
Reasons for instability of bacterial vaccinesM J CorbelDevelopments in Biological Standardization|January 1, 1996
A varicella vaccine stable at 5 degrees CB Fanget, A FrançonDevelopments in Biological Standardization|January 1, 1996
Stabilisation of poliovirus with pirodavirB Rombaut, K Andries, A BoeyéDevelopments in Biological Standardization|January 1, 1996
Stability of recombinant vaccinia-rabies vaccine in veterinary useP P Pastoret, B Brochier, B Languet, et al.Developments in Biological Standardization|January 1, 1996
Stability testing in Haemophilus influenzae type b conjugate vaccinesB KlugDevelopments in Biological Standardization|January 1, 1996
Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccineS P Schwendeman, H R Costantino, R K Gupta, et al.Developments in Biological Standardization|January 1, 1996
Regulatory requirements for veterinary vaccine stability in the European CommunityD FawthropPageof 220